CoChat

Myostatin and Sarcopenia: Opportunities and Challenges - A Mini-Review

White, Thomas A., LeBrasseur, Nathan K. · 2014 · Gerontology

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

The progressive loss of skeletal muscle mass, strength and/or function with advancing age, termed sarcopenia, poses a major threat to independence and quality of life. Therefore, there is significant merit in better understanding the biology of sarcopenia and developing therapeutic interventions to prevent, slow or reverse its progression. Since the discovery of myostatin, a potent negative regulator of growth that is highly enriched in skeletal muscle, there has been great interest in it as a potential mediator of sarcopenia as well as a therapeutic target. The complex biology of myostatin, the promise of myostatin inhibition as an effective means to counter sarcopenia, and the challenges facing its clinical translation are reviewed herein.

Overview

Integrity signals

Registry

Crossref · 10.1159/000356740

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. 10.1172/JCI13562 · doi:10.1172/jci13562 · Paper page

Cited by

See all 191

Metadata

Authors
White, T. A., & LeBrasseur, N. K.
Affiliations
Mayo Clinic (US)
Venue
Gerontology
Publisher
S. Karger AG
Published
2014
Volume
60
Issue
4
Pages
289-293
ISSN
  • 0304-324X (ISSN-L)
  • 1423-0003
OpenAlex
W2006774297
Cited by
191
References
32
Citations by year
2026: 11 · 2025: 12 · 2024: 14 · 2023: 23 · 2022: 17 · 2021: 25 · 2020: 17 · 2019: 16 · 2018: 12 · 2017: 13 · 2016: 14 · 2015: 7 · 2014: 10
FWCI
1.38
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Gerontology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Mayo Clinic
  • Center for Cell Signaling in Gastroenterology, Mayo Clinic
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK084567)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
myostatin, sarcopenia, skeletal muscle atrophy, muscle strength, aging, myostatin inhibition, therapeutic target, clinical translation, muscle growth regulation
MeSH terms
Aged, Aging, Animals, Humans, Signal Transduction, Muscle, Skeletal, Mice, Myostatin, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.